Feb 25 |
When Will Verona Pharma plc (NASDAQ:VRNA) Turn A Profit?
|
Feb 15 |
Verona Pharma: A Few Points From The Bull And Bear Case
|
Feb 15 |
Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
|
Feb 1 |
Michael Austwick Joins Verona Pharma as Non-Executive Director
|
Jan 19 |
Verona Pharma: Upcoming PDUFA, Expired Patent, Strong Data
|
Jan 15 |
Verona Pharma plc's (NASDAQ:VRNA) latest 11% decline adds to one-year losses, institutional investors may consider drastic measures
|
Jan 3 |
Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference
|
Jan 2 |
Verona Pharma enters upto $400M debt facility
|
Jan 2 |
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital
|
Dec 30 |
3 Stocks That Could Be Monster Winners in 2024
|